Cargando…
Facilitating the Cellular Accumulation of Pt-Based Chemotherapeutic Drugs
Cisplatin, carboplatin, and oxaliplatin are Pt-based drugs used in the chemotherapeutic eradication of cancer cells. Although most cancer patient cells initially respond well to the treatment, the clinical effectiveness declines over time as the cancer cells develop resistance to the drugs. The Pt-b...
Autores principales: | Lambert, Ian Henry, Sørensen, Belinda Halling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121265/ https://www.ncbi.nlm.nih.gov/pubmed/30071606 http://dx.doi.org/10.3390/ijms19082249 |
Ejemplares similares
-
Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21(Waf1/Cip1), and Caspase-9/-3 activation
por: Sørensen, Belinda Halling, et al.
Publicado: (2016) -
PT716. Treatment with the Chemotherapeutic Drug Methotrexate Impairs Long-Term Potentiation in the Hippocampus
por: Pechnick, Robert, et al.
Publicado: (2016) -
The effects of chemotherapeutics on cellular metabolism and consequent immune recognition
por: Newell, M Karen, et al.
Publicado: (2004) -
Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
por: Buchtova, Tereza, et al.
Publicado: (2023) -
Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis
por: Tai, Cheng-Jeng, et al.
Publicado: (2010)